Search Within

Lara Dunn

Formats
  1. Meeting Abstract (81)
  2. Journal Article (50)
  3. Review (7)
  4. Book Section (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (141)
  2. Head and Neck Service (141)
  3. Solid Tumor Oncology Division (141)
  4. Weinberg Fellows (141)
  5. Radiation Oncology, Department of (72)
  6. Surgery (65)

More Groups

People
  1. Eric Sherman (77)
  2. David Pfister (60)
  3. Nancy Lee (60)
  4. Sean McBride (57)
  5. Alan Ho (54)
  6. Nadeem Riaz (52)

More People

Years
  1. 2025 (3)
  2. 2024 (22)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. International Journal of Radiation Oncology, Biology, Physics (24)
  3. Annals of Oncology (9)
  4. Journal for ImmunoTherapy of Cancer (8)
  5. Head & Neck (6)
  6. Oral Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. Elsevier Inc. (30)
  3. Oxford University Press (10)
  4. Biomed Central Ltd (8)
  5. John Wiley & Sons, Inc. (6)
  6. Wiley Blackwell (6)

More Publishers

Results (141)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II single arm trial of induction and concurrent vismodegib with curative intent radiation therapy for locally advanced, unresectable basal cell carcinoma of the head and neck
    Meeting Abstract

    Barker, C. A.; Arron, S.; Ho, A.; Algazi, A.; Dunn, L.; Humphries, A.; Hultman, C.; Lian, M.; Knott, P. D.; Yom, S. S.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A pilot study evaluating selective minimal residual disease directed adjuvant radiation in human papilloma virus associated oropharynx carcinoma
    Meeting Abstract

    Chen, L.; Cohen, M.; Hatzoglou, V.; Zhang, Z.; Ganly, I.; Boyle, J. O.; Singh, B.; Morris, L. G.; Wong, R. J.; Cracchiolo, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
    Journal Article

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. Y.; Mohan, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Oncology for the rhinologist
    Review

    Tam, K.; Dunn, L. A.; Cohen, M. A.
    Current Opinion in Otolaryngology & Head and Neck Surgery (2024)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
    Journal Article

    Oliveira, G.; Egloff, A. M.; Afeyan, A. B.; Wolff, J. O.; Zeng, Z.; Chernock, R. D.; Zhou, L.; Messier, C.; Lizotte, P.; Pfaff, K. L.; more...
    Science Immunology (2023)

    Fulltext@MSK | Save
  • A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
    Meeting Abstract

    Desilets, A.; Pfister, D. G.; Wong, W.; Sherman, E. J.; Fetten, J. V.; Hung, K. W.; Dunn, L.; Ho, A. L.; Michel, L. S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, given as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer
    Meeting Abstract

    Chung, C. H.; Colevas, A. D. D.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Burtness, B.; Johnson, F. M.; Julian, R. A.; Saba, N. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save